Incretinas - Platinum - I International Congress on Incretins, Metabolism and Obesity

The 1st International Congress on Incretins, Metabolism, and Obesity is born at a time of transformation in clinical practice, where GLP-1 analogs are expanding the possibilities in the management of obesity, metabolism, and eating behavior.

This congress offers an objective, hands-on immersion, bringing together specialists from different fields to discuss the use of GLP-1 in real clinical practice, based on the most recent scientific evidence.

Beyond promoting weight loss, these therapies require an in-depth understanding of indication criteria, safety, treatment individualization, and integration with other clinical strategies.

The program covers everything from medical decision-making and understanding obesity as a disease, to the role of clinical nutrition, hospital experience, pre- and post-operative context, and the interface with mental health.

Under the scientific coordination of Dra. Vanessa Yuri Suzuki and Me. Andressa Rodrigues, the event brings together different professional perspectives to support clinical reasoning and patient management in GLP-1 use in a safer, more consistent, and individualized way, connecting evidence, clinical practice, and decision-making in contemporary care.